These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1691 related articles for article (PubMed ID: 24370890)

  • 1. Lessons from the heart: mirroring electrophysiological characteristics during cardiac development to in vitro differentiation of stem cell derived cardiomyocytes.
    van den Heuvel NH; van Veen TA; Lim B; Jonsson MK
    J Mol Cell Cardiol; 2014 Feb; 67():12-25. PubMed ID: 24370890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human-induced pluripotent stem cell-derived cardiomyocytes from cardiac progenitor cells: effects of selective ion channel blockade.
    Altomare C; Pianezzi E; Cervio E; Bolis S; Biemmi V; Benzoni P; Camici GG; Moccetti T; Barile L; Vassalli G
    Europace; 2016 Dec; 18(suppl 4):iv67-iv76. PubMed ID: 28011833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach.
    Sartiani L; Bettiol E; Stillitano F; Mugelli A; Cerbai E; Jaconi ME
    Stem Cells; 2007 May; 25(5):1136-44. PubMed ID: 17255522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrogen sulfide suppresses outward rectifier potassium currents in human pluripotent stem cell-derived cardiomyocytes.
    Wei H; Zhang G; Qiu S; Lu J; Sheng J; Manasi ; Tan G; Wong P; Gan SU; Shim W
    PLoS One; 2012; 7(11):e50641. PubMed ID: 23226343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-density plating is sufficient to induce cardiac hypertrophy and electrical remodeling in highly purified human iPS cell-derived cardiomyocytes.
    Uesugi M; Ojima A; Taniguchi T; Miyamoto N; Sawada K
    J Pharmacol Toxicol Methods; 2014; 69(2):177-88. PubMed ID: 24296355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cardiomyocyte generation from pluripotent stem cells: A state-of-art.
    Talkhabi M; Aghdami N; Baharvand H
    Life Sci; 2016 Jan; 145():98-113. PubMed ID: 26682938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.
    Zwi-Dantsis L; Huber I; Habib M; Winterstern A; Gepstein A; Arbel G; Gepstein L
    Eur Heart J; 2013 Jun; 34(21):1575-86. PubMed ID: 22621821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
    Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
    Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional maturation of human pluripotent stem cell derived cardiomyocytes in vitro--correlation between contraction force and electrophysiology.
    Ribeiro MC; Tertoolen LG; Guadix JA; Bellin M; Kosmidis G; D'Aniello C; Monshouwer-Kloots J; Goumans MJ; Wang YL; Feinberg AW; Mummery CL; Passier R
    Biomaterials; 2015 May; 51():138-150. PubMed ID: 25771005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents.
    Ma J; Guo L; Fiene SJ; Anson BD; Thomson JA; Kamp TJ; Kolaja KL; Swanson BJ; January CT
    Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H2006-17. PubMed ID: 21890694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing flecainide block of I
    Geng L; Kong CW; Wong AOT; Shum AM; Chow MZY; Che H; Zhang C; Yau KL; Chan CW; Keung W; Li RA
    Toxicol Lett; 2018 Sep; 294():61-72. PubMed ID: 29758359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular Matrix-Mediated Maturation of Human Pluripotent Stem Cell-Derived Cardiac Monolayer Structure and Electrophysiological Function.
    Herron TJ; Rocha AM; Campbell KF; Ponce-Balbuena D; Willis BC; Guerrero-Serna G; Liu Q; Klos M; Musa H; Zarzoso M; Bizy A; Furness J; Anumonwo J; Mironov S; Jalife J
    Circ Arrhythm Electrophysiol; 2016 Apr; 9(4):e003638. PubMed ID: 27069088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a scalable suspension culture for cardiac differentiation from human pluripotent stem cells.
    Chen VC; Ye J; Shukla P; Hua G; Chen D; Lin Z; Liu JC; Chai J; Gold J; Wu J; Hsu D; Couture LA
    Stem Cell Res; 2015 Sep; 15(2):365-75. PubMed ID: 26318718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Passive Stretch Induces Structural and Functional Maturation of Engineered Heart Muscle as Predicted by Computational Modeling.
    Abilez OJ; Tzatzalos E; Yang H; Zhao MT; Jung G; Zöllner AM; Tiburcy M; Riegler J; Matsa E; Shukla P; Zhuge Y; Chour T; Chen VC; Burridge PW; Karakikes I; Kuhl E; Bernstein D; Couture LA; Gold JD; Zimmermann WH; Wu JC
    Stem Cells; 2018 Feb; 36(2):265-277. PubMed ID: 29086457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes.
    Hemmi N; Tohyama S; Nakajima K; Kanazawa H; Suzuki T; Hattori F; Seki T; Kishino Y; Hirano A; Okada M; Tabei R; Ohno R; Fujita C; Haruna T; Yuasa S; Sano M; Fujita J; Fukuda K
    Stem Cells Transl Med; 2014 Dec; 3(12):1473-83. PubMed ID: 25355733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Learn from Your Elders: Developmental Biology Lessons to Guide Maturation of Stem Cell-Derived Cardiomyocytes.
    Marchianò S; Bertero A; Murry CE
    Pediatr Cardiol; 2019 Oct; 40(7):1367-1387. PubMed ID: 31388700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recording of multiple ion current components and action potentials in human induced pluripotent stem cell-derived cardiomyocytes via automated patch-clamp.
    Mann SA; Heide J; Knott T; Airini R; Epureanu FB; Deftu AF; Deftu AT; Radu BM; Amuzescu B
    J Pharmacol Toxicol Methods; 2019; 100():106599. PubMed ID: 31228558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes Under Defined Conditions.
    van den Berg CW; Elliott DA; Braam SR; Mummery CL; Davis RP
    Methods Mol Biol; 2016; 1353():163-80. PubMed ID: 25626427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming the promise of pluripotent stem cell-derived cardiomyocytes to a therapy: challenges and solutions for clinical trials.
    Prowse AB; Timmins NE; Yau TM; Li RK; Weisel RD; Keller G; Zandstra PW
    Can J Cardiol; 2014 Nov; 30(11):1335-49. PubMed ID: 25442434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complex aberrant splicing in the induced pluripotent stem cell-derived cardiomyocytes from a patient with long QT syndrome carrying KCNQ1-A344Aspl mutation.
    Wuriyanghai Y; Makiyama T; Sasaki K; Kamakura T; Yamamoto Y; Hayano M; Harita T; Nishiuchi S; Chen J; Kohjitani H; Hirose S; Yokoi F; Gao J; Chonabayashi K; Watanabe K; Ohno S; Yoshida Y; Kimura T; Horie M
    Heart Rhythm; 2018 Oct; 15(10):1566-1574. PubMed ID: 29857160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 85.